News
MODULATING DNA DAMAGE RESPONSES TO CURE CANCER
Contact Us
Breakpoint Therapeutics GmbH
Essener Bogen 7
22419 Hamburg (Germany)
Telefon: +49 40 56081 180
E-mail: info@breakpointtx.com
Impressum
Registergericht: Hamburg
Registernummer: HRB 155717
Umsatzsteuer-Identifikationsnummer: DE 324 797 830
Geschäftsführer / Managing Directors
Dr. Daniel Speidel and Jonathan Hollick
Breakpoint To Present At Biotech Showcase
Breakpoint’s Managing Director Daniel Speidel will present a company overview during JPM at Biotech Showcase in San Francisco on January 9, 2024. Hilton Union Square 2:15 pm, Franciscan C.
Breakpoint to Present At Tumour Models London Summit
Breakpoint’s Managing Director Jon Hollick will present a talk entitled “Decoding DNA Damage Response (DDR) Efficacy in Tumour Models to Advance Translation into the Clinic” at the 12th Annual Tumour Models London Summit (06-07 December 2023). He will also participate in the opening plenary panel discussing “How Do You Select the Best Model for Your […]
Breakpoint To Present At LSX Inv€$tival Showcase
Breakpoint’s Managing Director Jon Hollick will present a company overview at the LSX Inv€$tival Showcase in London on November 13, 2023.